803 related articles for article (PubMed ID: 33031856)
1. Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
Darwesh AM; Bassiouni W; Sosnowski DK; Seubert JM
Pharmacol Ther; 2021 Mar; 219():107703. PubMed ID: 33031856
[TBL] [Abstract][Full Text] [Related]
2. Effects of Omega-3 Polyunsaturated Fatty Acids and Their Metabolites on Haemostasis-Current Perspectives in Cardiovascular Disease.
Golanski J; Szymanska P; Rozalski M
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673634
[TBL] [Abstract][Full Text] [Related]
3. Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
Torrinhas RS; Calder PC; Lemos GO; Waitzberg DL
Nutrition; 2021 Jan; 81():110900. PubMed ID: 32738510
[TBL] [Abstract][Full Text] [Related]
4. Potential Benefits of Omega-3 Polyunsaturated Fatty Acids (N3PUFAs) on Cardiovascular Health Associated with COVID-19: An Update for 2023.
Lu LW; Quek SY; Lu SP; Chen JH
Metabolites; 2023 May; 13(5):. PubMed ID: 37233671
[TBL] [Abstract][Full Text] [Related]
5. Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19.
Yang CP; Chang CM; Yang CC; Pariante CM; Su KP
Brain Behav Immun; 2022 Jul; 103():19-27. PubMed ID: 35390469
[TBL] [Abstract][Full Text] [Related]
6. May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?
Weill P; Plissonneau C; Legrand P; Rioux V; Thibault R
Biochimie; 2020 Dec; 179():275-280. PubMed ID: 32920170
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
Schunck WH; Konkel A; Fischer R; Weylandt KH
Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
[TBL] [Abstract][Full Text] [Related]
8. Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021.
Djuricic I; Calder PC
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371930
[TBL] [Abstract][Full Text] [Related]
9. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19.
Rogero MM; Leão MC; Santana TM; Pimentel MVMB; Carlini GCG; da Silveira TFF; Gonçalves RC; Castro IA
Free Radic Biol Med; 2020 Aug; 156():190-199. PubMed ID: 32653511
[TBL] [Abstract][Full Text] [Related]
10. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid.
Siriwardhana N; Kalupahana NS; Moustaid-Moussa N
Adv Food Nutr Res; 2012; 65():211-22. PubMed ID: 22361189
[TBL] [Abstract][Full Text] [Related]
11. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Involvement of COVID-19: A Comprehensive Review.
Chang WT; Toh HS; Liao CT; Yu WL
Am J Med Sci; 2021 Jan; 361(1):14-22. PubMed ID: 33187633
[TBL] [Abstract][Full Text] [Related]
13. N-3 polyunsaturated fatty acids may affect the course of COVID-19.
Lampova B; Doskocil I; Kourimska L; Kopec A
Front Immunol; 2022; 13():957518. PubMed ID: 36238306
[TBL] [Abstract][Full Text] [Related]
14. Fortification of foods with omega-3 polyunsaturated fatty acids.
Ganesan B; Brothersen C; McMahon DJ
Crit Rev Food Sci Nutr; 2014; 54(1):98-114. PubMed ID: 24188235
[TBL] [Abstract][Full Text] [Related]
15. The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review.
Mazidimoradi A; Alemzadeh E; Alemzadeh E; Salehiniya H
Life Sci; 2022 Jun; 299():120489. PubMed ID: 35358595
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art.
Watanabe Y; Tatsuno I
Expert Rev Clin Pharmacol; 2021 Jan; 14(1):79-93. PubMed ID: 33306922
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
19. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
[TBL] [Abstract][Full Text] [Related]
20. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
